Neurophysiological Molecular and Developmental Analysis of the Glutamate Synapse in Autism (NMDA-Autism)

This study has been completed.

Sponsor:

ClinicalTrials.gov Identifier:

NCT01770548

First Posted: January 17, 2013

Last Update Posted: January 16, 2017

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

Information provided by (Responsible Party):

University Hospital, Tours

Purpose

Neurophysiological, Molecular and Developmental Analysis of the glutamate synapse in Autism

Condition	Intervention
Autism	Genetic: analysis of the glutamate synapse in autism Genetic: DNA collection Other: Auditory evoked potentials


Study Type:	Interventional
Study Design:	Allocation: Non-Randomized Intervention Model: Parallel Assignment Masking: None (Open Label)
Official Title:	Autism and Glutamatergic Synapse : Research of Genetic Mutations and Identification of Clinical and Neurophysiological Markers.

Further study details as provided by University Hospital, Tours:

Primary Outcome Measures:

screening of about 50 genes encoding proteins of the NMDA receptor complex, chosen according to their chromosomal localisation located in hotspots depicted by genome-wide screens in large population of autistic patients [ Time Frame: two years ]


Enrollment:	497
Study Start Date:	January 2009
Study Completion Date:	June 2014
Primary Completion Date:	January 2011 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
Experimental: Autism Analysis of the glutamate synapse in autism	Genetic: analysis of the glutamate synapse in autism Neurophysiological, molecular and developmental analysis of the glutamate synapse in autism Genetic: DNA collection DNA collection Other: Auditory evoked potentials auditory evoked potentials
Relative Analysis of the glutamate synapse in autism	Genetic: analysis of the glutamate synapse in autism Neurophysiological, molecular and developmental analysis of the glutamate synapse in autism Genetic: DNA collection DNA collection Other: Auditory evoked potentials auditory evoked potentials
Major control DNA collection	Genetic: analysis of the glutamate synapse in autism Neurophysiological, molecular and developmental analysis of the glutamate synapse in autism Genetic: DNA collection DNA collection Other: Auditory evoked potentials auditory evoked potentials
Minor control auditory evoked potentials	Other: Auditory evoked potentials auditory evoked potentials

Detailed Description:

Analysis about 50 genes in glutamate synapse

Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:	2 Years and older (Child, Adult, Senior)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

have a Pervasive Developmental Disorder

Exclusion Criteria:

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01770548

Locations


France
CHRU - Centre de Ressources Autisme (CRA)
Brest, France, 29000
CHS du ROUVRAY
Rouen, France, 76000
Chru - Cic
Tours, France, 37000
CHRU - Pédopsychiatrie
Tours, France, F-37000

Sponsors and Collaborators

University Hospital, Tours

Investigators


Study Director:	Frédérique BONNET-BRILHAULT, MD PHD	University François Rabelais of TOURS

More Information

Publications:

Bonnet-Brilhault F, Alirol S, Blanc R, Bazaud S, Marouillat S, Thépault RA, Andres CR, Lemonnier É, Barthélémy C, Raynaud M, Toutain A, Gomot M, Laumonnier F. GABA/Glutamate synaptic pathways targeted by integrative genomic and electrophysiological explorations distinguish autism from intellectual disability. Mol Psychiatry. 2016 Mar;21(3):411-8. doi: 10.1038/mp.2015.75. Epub 2015 Jun 9.


Responsible Party:	University Hospital, Tours
ClinicalTrials.gov Identifier:	NCT01770548 History of Changes
Other Study ID Numbers:	AORT08-FBB/NMDA-Autism 2008-A01162-53 ( Other Identifier: ID RCB )
First Submitted:	January 15, 2013
First Posted:	January 17, 2013
Last Update Posted:	January 16, 2017
Last Verified:	January 2017

Additional relevant MeSH terms:


Autistic Disorder Child Development Disorders, Pervasive Neurodevelopmental Disorders Mental Disorders

To Top